Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsPreferred Shares RepurchasedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PharmaCyte Biotech (PMCB) Shares Issued (2016 - 2023)

PharmaCyte Biotech (PMCB) has disclosed Shares Issued for 13 consecutive years, with $70.0 as the latest value for Q3 2023.

  • Quarterly Shares Issued fell 92.05% to $70.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $70.0 through Apr 2024, down 100.0% year-over-year, with the annual reading at $70.0 for FY2024, 92.05% down from the prior year.
  • Shares Issued for Q3 2023 was $70.0 at PharmaCyte Biotech, down from $4.7 million in the prior quarter.
  • The five-year high for Shares Issued was $4.7 million in Q1 2023, with the low at -$899.0 in Q4 2021.
  • Average Shares Issued over 5 years is $1.1 million, with a median of $473750.0 recorded in 2019.
  • The sharpest move saw Shares Issued soared 844.14% in 2020, then plummeted 100.03% in 2021.
  • Over 5 years, Shares Issued stood at $301000.0 in 2019, then skyrocketed by 844.14% to $2.8 million in 2020, then plummeted by 100.03% to -$899.0 in 2021, then surged by 197.89% to $880.0 in 2022, then crashed by 92.05% to $70.0 in 2023.
  • According to Business Quant data, Shares Issued over the past three periods came in at $70.0, $4.7 million, and $880.0 for Q3 2023, Q1 2023, and Q3 2022 respectively.